Skip to content

Study · Measured the body's own peptide · 2011

2 results

Thymosin beta 4 is associated with collateral development in coronary artery disease.

Biçer A, Karakurt Ö, Akdemir R, Erden G, Yildiz A, Özcan Ö, Sezen Y, Açikel S, Kiliç H, Demirbağ R

Scandinavian journal of clinical and laboratory investigation30 Aug 2011Cited by 10 (Europe PMC)

PMID21877905 (opens in a new tab)DOI10.3109/00365513.2011.599417 (opens in a new tab)PepBankPUB-21877905
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Natural levels measured2

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In patients with severely stenotic coronary artery disease, serum Tβ4 levels were significantly higher in the well-collateralized group than in the poorly collateralized group.

    In plain wordsIn people with severe coronary artery disease, the body's own thymosin beta‑4 was higher in those with good collateral vessels.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    IncreaseSerum Tβ4 level in well versus poorly collateralized patients
    Study

    n = 29

    Comparator
    Poorly collateralized group
    Outcome group
    Cardiovascular events · Cardiovascular

    Source sentences

    Summary
    The Tβ4 levels in the well-collateralized study group were found to be significantly higher than those of the poorly collateralized study group
    1 context sentence
    Summary · context
    Thirteen patients with poor collateral development and 16 age- and sex-matched patients with good collateral development who had ≥ 95% stenosis in at least one major coronary artery on coronary angiogram (CAG) were enrolled in the study.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

  2. 02HumanEndogenous levelObservational studyOther

    In patients with severely stenotic coronary artery disease, serum Tβ4 levels were positively correlated with collateral development.

    In plain wordsIn people with severe coronary artery disease, higher natural thymosin beta‑4 levels were linked to better collateral vessel development.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    IncreaseCorrelation of serum Tβ4 with collateral development
    Study

    n = 29

    Outcome group
    Cardiovascular events · Cardiovascular

    Source sentences

    Summary
    serum Tβ4 levels were positively correlated with the collateral development.
    1 context sentence
    Summary · context
    Thirteen patients with poor collateral development and 16 age- and sex-matched patients with good collateral development who had ≥ 95% stenosis in at least one major coronary artery on coronary angiogram (CAG) were enrolled in the study.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.